Evidence map›Paper›PMID 42665662›Full record

ArticleNature structural & molecular biology2026

Structural and mechanistic insights into gating and allosteric modulation of GluN1-GluN3A NMDA receptors.

Junhoe Kim, Avery J Benton, James S Lotti, Nirvan Rouzbeh, Kasper B Hansen, Eric Gouaux

Abstract read
In one paragraph

Article in Nature structural & molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Junhoe KimVollum Institute, Oregon Health and Science University, Portland, OR, USA.ORCID http://orcid.org/0000-0001-5866-9952
Avery J BentonCenter for Structural and Functional Neuroscience, Center for Biomolecular Structure and Dynamics, Division of Biological and Biomedical Sciences, University of Montana, Missoula, MT, USA.ORCID http://orcid.org/0000-0001-9063-6712
James S LottiCenter for Structural and Functional Neuroscience, Center for Biomolecular Structure and Dynamics, Division of Biological and Biomedical Sciences, University of Montana, Missoula, MT, USA.ORCID http://orcid.org/0000-0003-4541-1359
Nirvan RouzbehCenter for Structural and Functional Neuroscience, Center for Biomolecular Structure and Dynamics, Division of Biological and Biomedical Sciences, University of Montana, Missoula, MT, USA.
Kasper B HansenCenter for Structural and Functional Neuroscience, Center for Biomolecular Structure and Dynamics, Division of Biological and Biomedical Sciences, University of Montana, Missoula, MT, USA. kasper.hansen@umontana.edu.ORCID http://orcid.org/0000-0002-3303-4819
Eric GouauxVollum Institute, Oregon Health and Science University, Portland, OR, USA. gouauxe@ohsu.edu.ORCID http://orcid.org/0000-0002-8549-2360

Funding

Pacific Northwest Center for Cryo-EM: Equipment SupplementR24GM154185 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI James E Evans, CLAUDIA SUSANA LOPEZ · 2024 to 2026
$21.5M
Surveillance genome sequencing to detect SARS-CoV-2 virus variants in MontanaP30GM140963 · NIGMS · UNIVERSITY OF MONTANA · PI BOWLER, BRUCE E · 2021 to 2025
$6.9M
3D STRUCTURE/FUNCTION OF LIGAND GATED ION CHANNELSR01NS038631 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI GOUAUX, JAMES E · 1999 to 2024
$6.7M
Structural and functional investigation of negative allosteric NMDA receptor modulationR01NS097536 · NINDS · UNIVERSITY OF MONTANA · PI Kasper Boe Hansen · 2016 to 2026
$3.4M
High Performance Computing and Machine Learning Infrastructure for Oregon Life SciencesS10OD034224 · OD · OREGON HEALTH & SCIENCE UNIVERSITY · PI ELLROTT, KYLE · 2023 to 2023
$2.0M
Physiology and pharmacology of GluN3-containing NMDA receptorsR01NS116055 · NINDS · UNIVERSITY OF MONTANA · PI HANSEN, KASPER BOE · 2021 to 2025
$1.8M
NIGMS NIH HHS P30 GM140963NIGMS NIH HHS R24 GM154185NIH HHS S10 OD034224NINDS NIH HHS R01 NS038631NINDS NIH HHS R01 NS097536NINDS NIH HHS R01 NS116055
6 · The paper itself

Abstract

N-methyl-D-aspartate receptors (NMDARs) mediate excitatory signaling essential for synaptic plasticity and memory. Unlike GluN2-containing NMDARs, GluN3-containing receptors are activated solely by glycine and exhibit profound desensitization and paradoxical potentiation by GluN1-selective antagonists, including CGP-78608 (CGP). Although GluN3A-containing NMDARs regulate synapse pruning and excitotoxicity, and are associated with schizophrenia, autism and stroke, their native stoichiometry and gating mechanism are poorly defined. Here, using single-molecule pull-down analysis, we show that native GluN3A-containing receptors are diheteromeric assemblies. Cryogenic-electron microscopy analysis of GluN1-GluN3A receptors in antagonist-bound, preactive, active and desensitized states, augmented by electrophysiology and pharmacology experiments, show how glycine activates the receptor solely via GluN3A-dependent conformational changes, opening the gate with two-fold symmetry, and induces a roughly four-fold symmetric desensitized state. CGP-bound GluN1 restricts GluN3A rotation, promoting glycine-induced activation by blocking desensitization. These findings illuminate how CGP potentiates GluN1-GluN3A receptor activity, place the receptor gating mechanism on a structural foundation and define the molecular basis for pharmacological modulation.

Indexed as

Receptors, N-Methyl-D-AspartateAllosteric RegulationAnimalsCryoelectron MicroscopyGlycineHumansIon Channel GatingModels, MolecularProtein ConformationGlycineReceptors, N-Methyl-D-Aspartate

Identifiers

PMID42665662
PMCPMC13561882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.